Difference between revisions of "Medical Reporting/Vaccine and Treatment News"

From Atlanta Crisis Info Wiki
Jump to navigation Jump to search
(Treatment News)
(Treatment News)
Line 26: Line 26:
  
 
==Treatment News==
 
==Treatment News==
* 30 APR 2020 [https://www.cnn.com/2020/04/29/health/gilead-sciences-remdesivir-covid-19-treatment/index.html FDA will reportedly authorize use of remdesivir for Covid-19 after trial shows 'positive effect' on recovery time]
+
* 30 APR 2020 [https://www.cnn.com/2020/04/29/health/gilead-sciences-remdesivir-covid-19-treatment/index.html FDA will reportedly authorize use of remdesivir for Covid-19 after trial shows 'positive effect' on recovery time] - '''see also counterpoint: [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial]
 
* '''29 APR 2020 [https://www.cnbc.com/2020/04/29/dr-anthony-fauci-says-data-from-remdesivir-coronavirus-drug-trial-shows-quite-good-news.html?fbclid=IwAR0TTpngH_BIzdMwBz0zNlzRS7jcJmknupUxmQ_B6aYD1GGlrXEUbkycLj8 Dr. Anthony Fauci says Gilead’s remdesivir will set a new ‘standard of care’ for coronavirus treatment]'''
 
* '''29 APR 2020 [https://www.cnbc.com/2020/04/29/dr-anthony-fauci-says-data-from-remdesivir-coronavirus-drug-trial-shows-quite-good-news.html?fbclid=IwAR0TTpngH_BIzdMwBz0zNlzRS7jcJmknupUxmQ_B6aYD1GGlrXEUbkycLj8 Dr. Anthony Fauci says Gilead’s remdesivir will set a new ‘standard of care’ for coronavirus treatment]'''
 
** White House health advisor Dr. Anthony Fauci said Wednesday that data from a coronavirus drug trial testing Gilead Sciences’ antiviral drug remdesivir showed “quite good news” and sets a new standard of care for Covid-19 patients.
 
** White House health advisor Dr. Anthony Fauci said Wednesday that data from a coronavirus drug trial testing Gilead Sciences’ antiviral drug remdesivir showed “quite good news” and sets a new standard of care for Covid-19 patients.

Revision as of 04:51, 30 April 2020

Medical Reporting and Research

Published for General Public Reading Minimal Requirement of being a verified major news outlet with a high unbiased rating on The Media Bias Chart and/or from reputable sources, such as research facilities and universities

Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research

Vaccine Research

Testing News

Treatment News

Fauci said the median time of recovery for patients taking the drug was 11 days, compared with 15 days in the placebo group. The results suggested a survival benefit, with a mortality rate of 8% for the group receiving remdesivir versus 11.6% for the placebo group, according to a statement from the National Institutes of Health released later Wednesday.

Treatment & COVID-19 Co-Morbidities

Dangerous Misinformation perpetuated by the Trmp Administration

Peer-Reviewed Research has been moved to Medical Reporting/Research - Academic and Professional